Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended | |
Oct. 31, 2013 | Dec. 13, 2013 | |
Document And Entity Information | ' | ' |
Entity Registrant Name | 'Emo Capital Corp. | ' |
Entity Central Index Key | '0001410708 | ' |
Document Type | '10-Q | ' |
Document Period End Date | 31-Oct-13 | ' |
Amendment Flag | 'false | ' |
Current Fiscal Year End Date | '--07-31 | ' |
Is Entity a Well-known Seasoned Issuer? | 'No | ' |
Is Entity a Voluntary Filer? | 'No | ' |
Is Entity's Reporting Status Current? | 'Yes | ' |
Entity Filer Category | 'Smaller Reporting Company | ' |
Entity Common Stock, Shares Outstanding | ' | 35,000,000 |
Document Fiscal Period Focus | 'Q1 | ' |
Document Fiscal Year Focus | '2013 | ' |
Balance_Sheets
Balance Sheets (USD $) | Oct. 31, 2013 | Jul. 31, 2013 |
Current Assets | ' | ' |
Cash and cash equivalents | $0 | $0 |
TOTAL CURRENT ASSETS | 0 | 0 |
TOTAL ASSETS | 0 | 0 |
Current Liabilities | ' | ' |
Loan Payable | 20,425 | 20,425 |
Shareholder loan | 13,425 | 13,425 |
TOTAL CURRENT LIABILITIES | 33,850 | 33,850 |
Stockholders' Equity (Deficit) | ' | ' |
Common Stock Authorized: $0.001 par value, 75,000,000 shares authorized | 5,000 | 5,000 |
Issued and Outstanding: 35,500,000 common shares as of April 30, 2013 and July 31, 2012 | 5,000 | 5,000 |
Additional paid in capital | 27,000 | 27,000 |
Stock Subscribed | 100,000 | 100,000 |
Subscription Receivable | -100,000 | -100,000 |
Deficit accumulated during the development stage | -65,850 | -65,850 |
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) | -33,850 | -33,850 |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $0 | $0 |
Balance_Sheets_Parenthetical
Balance Sheets (Parenthetical) (USD $) | Oct. 31, 2013 | Jul. 31, 2013 | 1-May-12 | Dec. 22, 2011 | Feb. 25, 2010 | 1-May-08 | Jul. 15, 2007 |
Statement of Financial Position [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Common Stock Par Value | $0.00 | $0.00 | $0.20 | $0.01 | $0.00 | $0.01 | $0.00 |
Common Stock Authorized | 75,000,000 | 75,000,000 | ' | 1,500 | ' | ' | ' |
Common Stock Issued and Outstanding | 5,000,000 | 5,000,000 | ' | ' | 125,000,000 | 21,000,000 | 14,000,000 |
Statements_of_Operations
Statements of Operations (USD $) | 3 Months Ended | 86 Months Ended | |
Oct. 31, 2013 | Oct. 31, 2012 | Oct. 31, 2013 | |
General and Administrative Expenses | ' | ' | ' |
Professional Fees | $0 | $2,550 | $62,364 |
Administration | 0 | 0 | 2,229 |
Filing Fee | 0 | 0 | 350 |
Bank charges and interest | 0 | 0 | 407 |
Advertising Fee | 0 | 0 | 500 |
Operating Loss | 0 | 2,550 | 65,850 |
Net loss | $0 | ($2,550) | ($65,850) |
Basic and diluted net loss per common share | $0 | $0 | ' |
Weighted average common shares | ' | ' | ' |
outstanding - basic and diluted | 35,500,000 | 35,500,000 | ' |
Statements_of_Cash_Flows
Statements of Cash Flows (USD $) | 3 Months Ended | 86 Months Ended | |
Oct. 31, 2013 | Oct. 31, 2012 | Oct. 31, 2013 | |
Cash Flows from Operating Activities | ' | ' | ' |
Net loss | $0 | ($8,429) | ($65,850) |
Changes in non-working capital items: | ' | ' | ' |
Cash and Cash Equivalents | ' | -529 | -584 |
Accounts payable and accrued liabilities | ' | 7,900 | 20,425 |
Net cash provided by (used in) operating activities | ' | -529 | -45,425 |
Financing Activities | ' | ' | ' |
Shareholder loan | ' | ' | 13,425 |
Share Capital Subscribed | ' | ' | 32,000 |
Net cash provided by financing activities | ' | ' | 45,425 |
Net increase (decrease) change in cash | ' | -529 | 0 |
Cash and cash equivalents balance, beginning of period | ' | 55 | ' |
Cash and cash equivalents balance, end of period | $0 | ' | $0 |
Nature_and_Continuance_of_Oper
Nature and Continuance of Operations | 3 Months Ended |
Oct. 31, 2013 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Nature and Continuance of Operations | ' |
1. NATURE AND CONTINUANCE OF OPERATIONS | |
The Company is a development stage company, which was incorporated in the State of Nevada, United States of America on August 23, 2006. The Company intends to commence operations in health and beauty care through the utilization of the web. | |
These financial statements have been prepared on a going concern basis. The Company has accumulated a deficit of $65,850 since inception and has yet to achieve profitable operations and further losses are anticipated in the development of its business, raising substantial doubt about the Company's ability to continue as a going concern. Its ability to continue as a going concern is dependent upon the ability of the Company to generate profitable operations in the future and or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management plans to continue to provide for its working capital needs by seeking loans from its shareholder. These financial statements do not include any adjustments to the recoverability and classification of assets, or the amount and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. | |
The company's year-end is July 31. |
Summary_of_Significant_Account
Summary of Significant Accounting Policies | 3 Months Ended |
Oct. 31, 2013 | |
Accounting Policies [Abstract] | ' |
Summary of Significant Accounting Policies | ' |
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
The financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates, which have been made using careful judgment. Actual results may vary from these estimates. | |
The financial statements have, in management's opinion, been properly prepared within the framework of the significant accounting policies summarized below: | |
Cash and Cash Equivalents | |
Cash equivalents comprise certain highly liquid instruments with maturities of three months or less when purchased. As at October 31, 2013, there were Cash and Cash Equivalents equal to $584. | |
Development Stage Company | |
The Company complies with the FASB Accounting Standards Codification (ASC) Topic 915 Development Stage Entities and the Securities and Exchange Commission Exchange Act 7 for its characterization of the Company as development stage. | |
Impairment of Long Lived Assets | |
Long-lived assets are reviewed for impairment in accordance with ASC Topic 360, "Accounting for the Impairment or Disposal of Long- lived Assets". Under ASC Topic 360, long-lived assets are tested for recoverability whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. An impairment charge is recognized or the amount, if any, which the carrying value of the asset exceeds the fair value. | |
Foreign Currency Translation | |
The Company is located and operating outside of the United States of America. It maintains its accounting records in U.S. Dollars, as follows: | |
At the transaction date, each asset, liability, revenue, and expense is translated into U.S. dollars by the use of exchange rates in effect at that date. At the period end, monetary assets and liabilities are remeasured by using the exchange rate in effect at that date. The resulting foreign exchange gains and losses are included in operations. | |
The Company's currency exposure is insignificant and immaterial and we do not use derivative instruments to reduce its potential exposure to foreign currency risk. | |
Financial Instruments | |
The carrying value of the Company's financial instruments consisting of cash equivalents and accounts payable and accrued liabilities approximates their fair value because of the short maturity of these instruments. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest, currency or credit risks arising from these financial instruments. | |
Income Taxes | |
The Company uses the assets and liability method of accounting for income taxes in accordance with FASB Topic 740 “Income Taxes". Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. | |
Basic and Diluted Net Loss Per Share | |
In accordance with FASB Topic 260, "Earnings Per Share', the basic net loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted net loss per common share is computed similar to basic net loss per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. As at October 31, 2013, diluted net loss per share is equivalent to basic net loss per share. | |
Stock Based Compensation | |
The Company accounts for stock options and similar equity instruments issued in accordance with ASC Topic 718 Compensation-Stock Compensation. Accordingly, compensation costs attributable to stock options or similar equity instruments granted are measured at the fair value at the grant date, and expensed over the expected vesting period. Transactions in which goods or services are received in exchange for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. ASC Topic 718- Compensation requires excess tax benefits be reported as a financing cash inflow rather than as a reduction of taxes paid. | |
The Company did not grant any stock options during the period ended October 31, 2013. | |
Comprehensive Income | |
The Company adopted Statement of Financial Accounting Standards No. 130 (SFAS 130), Reporting Comprehensive Income, which establishes standards for reporting and display of comprehensive income, its components and accumulated balances. The Company is disclosing this information on its Statement of Stockholders' Equity. Comprehensive income comprises equity except those resulting from investments by owners and distributions to owners. | |
The Company has no elements of "other comprehensive income" during the period ended October 31, 2013. | |
Advertising Expenses | |
The company expenses advertising costs as incurred. There was no advertising expense incurred by the company during the period ended October 31, 2013. | |
New Accounting Standards | |
Management does not believe that any recently issued, but not yet effective accounting standards if currently adopted could have a material effect on the accompanying financial statements. |
Capital_Stock
Capital Stock | 3 Months Ended |
Oct. 31, 2013 | |
Equity [Abstract] | ' |
Capital Stock | ' |
3. CAPITAL STOCK | |
On July 15, 2007, the Company issued 14,000,000 common shares at $0.001 per share to the sole director of the Company for total proceeds of $2,000. | |
In May 2008, the Company issued 21,000,000 common shares at $0.01 per share to subscribers for total proceeds of $30,000. | |
On February 25, 2010, the Company amended its Articles of incorporation and authorized 125,000,000 shares of common stock, at $.001 par value of which 35,000,000 were issued and outstanding as of April 30, 2012. | |
On April 30, 2010, the Stockholder's of the Company authorized the Forward Stock Split of our issued and outstanding Common Stock on a seven for one (7:1) basis. The Forward Stock Split became effective on April 30, 2010. As a result of the Forward Stock Split, the Company increased its issued and outstanding shares of the Common Stock to 35,000,000 from 5,000,000. | |
In May 2012, the Company subscribed 500,000 restricted common shares at $0.20 per share to a shareholder for a subscription receivable of $100,000. |
Related_Party_Transactions
Related Party Transactions | 3 Months Ended |
Oct. 31, 2013 | |
Related Party Transactions [Abstract] | ' |
Related Party Transactions | ' |
4. RELATED PARTY TRANSACTIONS | |
A series of shareholder loans were made from August 23, 2006 to October 31, 2013 totaling $13,425. A balance of $13,425 is still outstanding as of October 31, 2013, without interest and fixed term of repayment. The loan is due at demand. |
Subsidiaries
Subsidiaries | 3 Months Ended |
Oct. 31, 2013 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Subsidiaries | ' |
5. SUBSIDIARIES | |
On December 22, 2011 the Company incorporated Nu Vitality Labs Inc., in the State of Nevada as a wholly owned subsidiary of Emo Capital Corp. Nu Vitality Labs Inc., has authorized common shares of 1500 shares par value .01 and all authorized shares have been issued to EMO Capital Corp. Emo Capital Corp. paid $150 for the shares of Nu Vitality Labs Inc. The attached financial statements were prepared using the consolidation method to account for the 100% wholly owned subsidiary, Nu Vitality Labs Inc., and Emo Capital Corp. for the period ended October 31, 2013. |
Summary_of_Significant_Account1
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Oct. 31, 2013 | |
Accounting Policies [Abstract] | ' |
Cash and Cash Equivalents | ' |
Cash and Cash Equivalents | |
Cash equivalents comprise certain highly liquid instruments with maturities of three months or less when purchased. As at October 31, 2013, there were Cash and Cash Equivalents equal to $584. | |
Development Stage Company | ' |
Development Stage Company | |
The Company complies with the FASB Accounting Standards Codification (ASC) Topic 915 Development Stage Entities and the Securities and Exchange Commission Exchange Act 7 for its characterization of the Company as development stage. | |
Impairment of Long Lived Assets | ' |
Impairment of Long Lived Assets | |
Long-lived assets are reviewed for impairment in accordance with ASC Topic 360, "Accounting for the Impairment or Disposal of Long- lived Assets". Under ASC Topic 360, long-lived assets are tested for recoverability whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. An impairment charge is recognized or the amount, if any, which the carrying value of the asset exceeds the fair value. | |
Foreign Currency Translation | ' |
Foreign Currency Translation | |
The Company is located and operating outside of the United States of America. It maintains its accounting records in U.S. Dollars, as follows: | |
At the transaction date, each asset, liability, revenue, and expense is translated into U.S. dollars by the use of exchange rates in effect at that date. At the period end, monetary assets and liabilities are remeasured by using the exchange rate in effect at that date. The resulting foreign exchange gains and losses are included in operations. | |
The Company's currency exposure is insignificant and immaterial and we do not use derivative instruments to reduce its potential exposure to foreign currency risk. | |
Financial Instruments | ' |
Financial Instruments | |
The carrying value of the Company's financial instruments consisting of cash equivalents and accounts payable and accrued liabilities approximates their fair value because of the short maturity of these instruments. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest, currency or credit risks arising from these financial instruments. | |
Income Taxes | ' |
Income Taxes | |
The Company uses the assets and liability method of accounting for income taxes in accordance with FASB Topic 740 “Income Taxes". Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. | |
Basic and Diluted Net Loss Per Share | ' |
Basic and Diluted Net Loss Per Share | |
In accordance with FASB Topic 260, "Earnings Per Share', the basic net loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted net loss per common share is computed similar to basic net loss per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. As at October 31, 2013, diluted net loss per share is equivalent to basic net loss per share. | |
Stock Based Compensation | ' |
Stock Based Compensation | |
The Company accounts for stock options and similar equity instruments issued in accordance with ASC Topic 718 Compensation-Stock Compensation. Accordingly, compensation costs attributable to stock options or similar equity instruments granted are measured at the fair value at the grant date, and expensed over the expected vesting period. Transactions in which goods or services are received in exchange for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. ASC Topic 718- Compensation requires excess tax benefits be reported as a financing cash inflow rather than as a reduction of taxes paid. | |
The Company did not grant any stock options during the period ended October 31, 2013. | |
Comprehensive Income | ' |
Comprehensive Income | |
The Company adopted Statement of Financial Accounting Standards No. 130 (SFAS 130), Reporting Comprehensive Income, which establishes standards for reporting and display of comprehensive income, its components and accumulated balances. The Company is disclosing this information on its Statement of Stockholders' Equity. Comprehensive income comprises equity except those resulting from investments by owners and distributions to owners. | |
The Company has no elements of "other comprehensive income" during the period ended October 31, 2013. | |
Advertising Expenses | ' |
Advertising Expenses | |
The company expenses advertising costs as incurred. There was no advertising expense incurred by the company during the period ended October 31, 2013. | |
New Accounting Standards | ' |
New Accounting Standards | |
Management does not believe that any recently issued, but not yet effective accounting standards if currently adopted could have a material effect on the accompanying financial statements. |
Nature_and_Continuance_of_Oper1
Nature and Continuance of Operations (Details Narrative) (USD $) | 86 Months Ended |
Oct. 31, 2013 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
[us-gaap:ProfitLoss] | $65,850 |
Capital_Stock_Details_Narrativ
Capital Stock (Details Narrative) (USD $) | Oct. 31, 2013 | Jul. 31, 2013 | 1-May-12 | Apr. 30, 2012 | Dec. 22, 2011 | Apr. 30, 2010 | Feb. 25, 2010 | 1-May-08 | Jul. 15, 2007 |
Equity [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
[us-gaap:CommonStockSharesIssued] | 5,000,000 | 5,000,000 | ' | ' | ' | ' | 125,000,000 | 21,000,000 | 14,000,000 |
[us-gaap:CommonStockParOrStatedValuePerShare] | $0.00 | $0.00 | $0.20 | ' | $0.01 | ' | $0.00 | $0.01 | $0.00 |
[us-gaap:CommonStockSharesSubscriptions] | $100,000 | $100,000 | ' | ' | $150 | ' | ' | $30,000 | $2,000 |
[us-gaap:CommonStockOtherSharesOutstanding] | ' | ' | ' | 35,000,000 | ' | 35,000,000 | ' | ' | ' |
[us-gaap:CommonStockValueOutstanding] | ' | ' | ' | ' | ' | 5,000,000 | ' | ' | ' |
[us-gaap:CommonStockSharesSubscribedButUnissued] | ' | ' | 500,000 | ' | ' | ' | ' | ' | ' |
[us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable] | ' | ' | $100,000 | ' | ' | ' | ' | ' | ' |
Related_Party_Transactions_Det
Related Party Transactions (Details Narrative) (USD $) | 3 Months Ended | 86 Months Ended | |
Oct. 31, 2013 | Oct. 31, 2012 | Oct. 31, 2013 | |
Related Party Transactions [Abstract] | ' | ' | ' |
[us-gaap:ProceedsFromLoans] | ' | ' | $13,425 |
[us-gaap:DueToRelatedPartiesCurrent] | $13,425 | ' | $13,425 |
Subsidiaries_Details_Narrative
Subsidiaries (Details Narrative) (USD $) | Oct. 31, 2013 | Jul. 31, 2013 | 1-May-12 | Dec. 22, 2011 | Feb. 25, 2010 | 1-May-08 | Jul. 15, 2007 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' | ' | ' | ' | ' | ' | ' |
[us-gaap:CommonStockSharesAuthorized] | 75,000,000 | 75,000,000 | ' | 1,500 | ' | ' | ' |
[us-gaap:CommonStockParOrStatedValuePerShare] | $0.00 | $0.00 | $0.20 | $0.01 | $0.00 | $0.01 | $0.00 |
[us-gaap:CommonStockSharesSubscriptions] | $100,000 | $100,000 | ' | $150 | ' | $30,000 | $2,000 |